4/15
01:38 am
qgen
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation [Yahoo! Finance]
Low
Report
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation [Yahoo! Finance]
4/15
01:30 am
qgen
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation
Low
Report
QIAGEN Advancing Plans to Launch Three New Sample Preparation Instruments by 2026 to Improve Lab Automation
4/8
11:22 am
qgen
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast
Medium
Report
QIAGEN N.V. to Release Results for Q1 2025 and Hold Webcast
4/6
02:28 pm
qgen
QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook
Medium
Report
QIAGEN Delivers Strong Preliminary Q1 2025 Results Exceeding Outlook and Raises Full-Year 2025 Adjusted EPS Outlook
4/4
09:13 am
qgen
Qiagen (NYSE: QGEN) was downgraded by analysts at Redburn Atlantic from a "buy" rating to a "neutral" rating.
Medium
Report
Qiagen (NYSE: QGEN) was downgraded by analysts at Redburn Atlantic from a "buy" rating to a "neutral" rating.
4/1
01:30 am
qgen
QIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts
Low
Report
QIAGEN Launches QIAprep& Plasmodium Kit to Strengthen Malaria Research and Surveillance Efforts
3/31
06:00 am
qgen
QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results
Low
Report
QIAGEN Announces Form 20-F Annual Report Filing for 2024 Results
3/19
07:07 am
qgen
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH [Yahoo! Finance]
Low
Report
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH [Yahoo! Finance]
3/19
07:05 am
qgen
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH [Globe and Mail, The (Toronto, Canada)]
Low
Report
Zymo Research Responds to Recent Court Ruling in Litigation with QIAGEN GmbH [Globe and Mail, The (Toronto, Canada)]
3/12
08:17 am
qgen
Is it Worth Retaining QIAGEN Stock in Your Portfolio Now? [Yahoo! Finance]
Low
Report
Is it Worth Retaining QIAGEN Stock in Your Portfolio Now? [Yahoo! Finance]
3/9
05:09 am
qgen
The past three-year earnings decline for Qiagen (NYSE:QGEN) likely explains shareholders long-term losses [Yahoo! Finance]
Low
Report
The past three-year earnings decline for Qiagen (NYSE:QGEN) likely explains shareholders long-term losses [Yahoo! Finance]
3/6
01:09 am
qgen
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio [Yahoo! Finance]
Low
Report
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio [Yahoo! Finance]
3/6
01:00 am
qgen
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
Low
Report
QIAGEN receives U.S. clearance for second QIAstat-Dx mini gastrointestinal panel, expanding U.S. syndromic testing portfolio
3/3
01:00 am
qgen
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
Low
Report
QIAGEN takes legal action to defend QuantiFERON intellectual property and protect innovations in latent tuberculosis testing
2/25
04:41 pm
qgen
Qiagen N.V.: Some Clarity Needed Before Buying The Dip [Seeking Alpha]
Low
Report
Qiagen N.V.: Some Clarity Needed Before Buying The Dip [Seeking Alpha]
2/20
05:47 am
qgen
Qiagen (NYSE: QGEN) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
Low
Report
Qiagen (NYSE: QGEN) was downgraded by analysts at Baird R W from a "strong-buy" rating to a "hold" rating.
2/19
09:00 am
qgen
Ambrosia Biosciences Further Strengthens Board of Directors with Appointment of Jason Haddock
Low
Report
Ambrosia Biosciences Further Strengthens Board of Directors with Appointment of Jason Haddock
2/19
07:06 am
qgen
Qiagen (NYSE: QGEN) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $42.00 price target on the stock, down previously from $52.00.
Low
Report
Qiagen (NYSE: QGEN) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $42.00 price target on the stock, down previously from $52.00.
2/17
02:33 pm
qgen
Europe's Liquid Biopsy Market Predicted to Surge, Forecasted to Reach $5.58 Billion by 2033 [Yahoo! Finance]
Low
Report
Europe's Liquid Biopsy Market Predicted to Surge, Forecasted to Reach $5.58 Billion by 2033 [Yahoo! Finance]
2/13
04:30 pm
qgen
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region [Yahoo! Finance]
Low
Report
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region [Yahoo! Finance]
2/13
04:05 pm
qgen
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
Low
Report
QIAGEN Strengthens Global Bioinformatics Leadership With New Data Center in Australia/Asia-Pacific Region
2/7
10:56 am
qgen
Qiagen (NYSE: QGEN) had its price target lowered by analysts at UBS Group AG from $50.00 to $48.00. They now have a "neutral" rating on the stock.
Low
Report
Qiagen (NYSE: QGEN) had its price target lowered by analysts at UBS Group AG from $50.00 to $48.00. They now have a "neutral" rating on the stock.
2/6
02:15 pm
qgen
Qiagen N.V. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
Low
Report
Qiagen N.V. 2024 Q4 - Results - Earnings Call Presentation [Seeking Alpha]
2/5
06:17 pm
qgen
Qiagen NV (QGEN) Q4 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
Medium
Report
Qiagen NV (QGEN) Q4 2024 Earnings Report Preview: What To Expect [Yahoo! Finance]
2/5
04:24 pm
qgen
QIAGEN delivers solid Q4 2024 growth ahead of outlook [Yahoo! Finance]
Medium
Report
QIAGEN delivers solid Q4 2024 growth ahead of outlook [Yahoo! Finance]